UniProtKB/Swiss-Prot P20585: Variant p.Ala1045Thr

DNA mismatch repair protein Msh3
Gene: MSH3
Feedback?

Variant information Variant position:

1045 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Alanine (A) to Threonine (T) at position 1045 (A1045T, p.Ala1045Thr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from small size and hydrophobic (A) to medium size and polar (T) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs26279 [ dbSNP | Ensembl ]

Sequence information Variant position:

1045 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

1137 The length of the canonical sequence.
Location on the sequence:

VGNYHMGFLVSEDESKLDPG A AEQVPDFVTFLYQITRGIAA The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         VGNYHMGFLVSEDESKLDPGAAEQVPDFVTFLYQITRGIAA

Mouse                         VGNYHMGFLVNEDESKQDSGDMEQMPDSVTFLYQITRGIAA

Slime mold                    VGNFHMGYL----EEKQDQQLQKSVIPKVIFLYKLVKGAAQ

Baker's yeast                 IRNYHMDYV---EEQKTGEDWM-----SVIFLYKLKKGLTY

Fission yeast                 LRCFHMGYL------KSKEDFETSVSQSISFLYKLVPGVAS

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 1137	DNA mismatch repair protein Msh3

Literature citations
Isolation and characterization of cDNA clones derived from the divergently transcribed gene in the region upstream from the human dihydrofolate reductase gene.
Fujii H.; Shimada T.;
J. Biol. Chem. 264:10057-10064(1989)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; VARIANTS VAL-79; ARG-949 AND THR-1045; Submission
Shimada T.; Ikejima M.; Watanabe A.; Orimo H.;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS VAL-79; ARG-949 AND THR-1045; Submission
NIEHS SNPs program;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS ALA-ALA-ALA-62 INS; VAL-79; LEU-709; ARG-949 AND THR-1045; The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
The MGC Project Team;
Genome Res. 14:2121-2127(2004)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]; VARIANTS 57-ALA--ALA-65 DEL; VAL-79; ARG-949 AND THR-1045; Association between single nucleotide polymorphisms in the hMSH3 gene and sporadic colon cancer with microsatellite instability.
Orimo H.; Nakajima E.; Yamamoto M.; Ikejima M.; Emi M.; Shimada T.;
J. Hum. Genet. 45:228-230(2000)
Cited for: VARIANTS VAL-79 AND THR-1045;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.